Related Experiment Video
Updated: May 6, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Progress in translational research on intracerebral hemorrhage: is there an end in sight?
Guohua Xi1, Jennifer Strahle1, Ya Hua1
1Department of Neurosurgery, University of Michigan, Ann Arbor, MI, United States.
Insights
Intracerebral hemorrhage (ICH) is a deadly stroke subtype lacking specific treatments. This review highlights translational research progress and ongoing clinical trials for ICH, offering hope for new therapies.
Area of Science:
- Neurology
- Translational Medicine
- Stroke Research
Background:
- Intracerebral hemorrhage (ICH) is a significant cause of stroke-related mortality and disability.
- Current therapeutic options for ICH are limited, necessitating advancements in understanding and treatment.
- Translational research is crucial for bridging basic science discoveries to clinical applications in ICH.
Purpose of the Study:
- To review the progress of translational studies investigating intracerebral hemorrhage (ICH).
- To cover the etiology, natural history, and impact of ICH on various physiological systems.
- To discuss current and future clinical trials for ICH management.
Main Methods:
- Literature review of experimental and translational studies on ICH.
- Analysis of research on ICH animal models and their relevance.
- Examination of studies on the immunological and cardiovascular effects of ICH.
- Synthesis of information on ongoing and proposed clinical trials for ICH.
Main Results:
- Significant progress has been made in understanding ICH pathophysiology through translational research.
- Animal models provide valuable insights into ICH mechanisms and potential therapeutic targets.
- ICH impacts immune and cardiac systems, offering avenues for novel treatment strategies.
- Several clinical trials are underway or planned to evaluate new ICH interventions.
Conclusions:
- Translational research is vital for developing effective therapies for intracerebral hemorrhage.
- Further investigation into ICH's systemic effects and refined clinical trial designs are needed.
- Advancements in understanding and treatment hold promise for improving outcomes in ICH patients.
Abstract:
Intracerebral hemorrhage (ICH) is a common and often fatal stroke subtype for which specific therapies and treatments remain elusive. To address this, many recent experimental and translational studies of ICH have been conducted, and these have led to several ongoing clinical trials. This review focuses on the progress of translational studies of ICH including those of the underlying causes and natural history of ICH, animal models of the condition, and effects of ICH on the immune and cardiac systems, among others. Current and potential clinical trials also are discussed for both ICH alone and with intraventricular extension.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology

